Skip to search.
 TSX Down 0.19% TSX Ventures Up 0.14%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
1.93 0.00(0.00%) Aug 29, 12:15PM EDT
Prev Close:1.93
Open:1.94
Bid:1.93
Ask:2.10
1y Target Est:N/A
Beta:2.54551
Next Earnings Date:N/A
Day's Range:1.93 - 1.95
52wk Range:0.89 - 3.54
Volume:7,200
Avg Vol (3m):13,786
Market Cap:74.88M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback